Peregrine Pharmaceuticals (PPHM) shares was up 7% in Pre-Market BioPharma Consumer Cyclicals Diversified Financial Macro Markets Software & ServicesApril 14, 2014 The stock price of Peregrine Pharmaceuticals (PPHM) was up 7% in Pre-Market. Sharing Twitter0 Facebook0 Google +0 Linkedinactive){li-icon[type=linkedin-bug][color=inverse] .background{fill Email this article Print this article Tags bavituximab, immunotherapeutic, NSCLC, Peregrine Pharmaceuticals, PPHM, SBRT, stereotactic